Saniona is proud to join EURORDIS-Rare Diseases Europe in its efforts to raise awareness and increase opportunity for the 300 million people worldwide living with a rare disease. #RareDiseaseDay2022

Saniona’s Chief Communications Officer, Trista Morrison, will present a company overview during Aktieportföljen, Per G Ohlin Live tomorrow at 8:45 AM ET. Tune in here: youtube.com/watch?v=4wH9fh…

Breaking News: Saniona Initiates Multiple Ascending Dose Stage of SAN711 Phase 1 Clinical Trial news.saniona.com/news-releases/…

Art pieces “Hope” and “Hopefull,” created by PWS patients, hang in our Glostrup and Waltham offices and serve as reminders that patients are counting on us. Thank you to the courageous families who shared their stories and art with us and to Prader-Willi Research for hosting the art auction.

At Saniona, 87% of our scientists are women. Watch our own Karin Sandager Nielsen and Nadia Lybøl von Schoubye talk about their career journeys and share advice for young women considering a career in #STEM. #womeninscience youtube.com/watch?v=D1oKYA…

Our President and CEO, Rami Levin, recently spoke with PharmaVoice on the importance of engaging patients and other stakeholders early to inform the development of rare disease treatments. Read more here: pharmavoice.com/news/sanionas-…

Sasha has a rare disease called Hypothalamic Obesity. Watch this video to hear Sasha’s story, and register to attend FDA's Rare Disease Day 2022 virtual public meeting to learn more about rare diseases: bit.ly/3grgIGl #RareDiseaseStories

Caregivers for people living with PWS and HO face difficult challenges every day. On #NationalCaregiversDay, Saniona recognizes their compassion, dedication and selfless efforts – thank you for all that you do.

Our President and CEO, Rami Levin, spoke with Pharmaceutical Executive about Saniona’s growth and expansion into the U.S., the need for continued innovation and “how critical it is to incorporate patient insights into everything you do when you work in #rarediseases.” bit.ly/3JBFnUY

Awareness is key in our mission to improve the lives of rare disease patients. In our Community Voices, series, we amplify voices of people in the PWS and HO communities to help generate change for patients, families, and caregivers. #RDD2022 Learn more: bit.ly/3FLjTmn

Breaking News: Saniona publishes its year-end report for 2021 #pharma #biotech #earnings bit.ly/3BKRDA1

On #RareDiseaseDay2022, our Saniona teams in #Glostrup and #Boston share what rare disease awareness means to them.

Saniona is a proud sponsor of MassBio’s #RareDiseaseDay event. Attendees will hear from industry leaders on efforts to address health inequality and racial disparities in the rare disease community. Join us: bit.ly/3zGI6cd #healthequity

Saniona’s Q4 Signals Value Ahead biostock.se/en/2022/03/san… #BioStockSwe #lifesciences Saniona

Breaking News: Saniona to participate in multiple upcoming investor conferences #investorrelations #biopharma #raredisease

Watch our President & CEO Rami Levin highlight Saniona’s investment thesis including near-term milestones for key clinical programs & the drug discovery engine fueling our portfolio as we execute on our vision to build an international rare disease company bit.ly/3hGlmAQ

This #IWD2022, we celebrate women who break glass ceilings, defy norms, and blaze their own trail – like our Chief Legal Officer, Denelle Waynick, who became the first African American partner at Gibbons law firm while also raising her son as a single mother.

Saniona’s Chief Corporate Affairs Officer, Trista Morrison, will present a company overview live in Sweden tomorrow at 1:00 PM ET at Redeye Gothenberg Forum. Register to watch here: bit.ly/3rVdp0A #investorrelations #biopharma #raredisease

With no access to treatment or specialised care, the 2 million people living with a rare disease in Ukraine are at risk in a number of ways, and we must act now to ensure they are not left behind. How? Read in our article published in European Medical Journal : cutt.ly/oAAXcwj

Saniona’s Chief Corporate Affairs Officer, Trista Morrison, will present a company overview live during Aktiespararna Stockholm Share Day today at 11:00 AM ET. Tune in here: bit.ly/3GYstyA #investorrelations #biopharma #raredisease